Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 11/03/2026#nephjc Jeyakumar from India Joining the party late 000
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 25/02/2026Check the insightful #NephJC summary by Jeyakumar Meyyappannephjc.com2026 KDIGO Anemia Management Guidelines — NephJCThis week, we will discuss 2026 KDIGO anemia management in patients with kidney disease 043
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 25/02/2026#nephjc Jeyakumar joining from Lucknow , India No COI 020
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 24/02/2026#NephSky #MedSky 🩸Blood is thicker than water 🌊 Thankfully we thinned out the 2026 KDIGO Anemia Guidelines for you to peruse. Come discuss what's new. Tuesday 2/24/26 at 9pm EST on Bluesky! Summary by @jeyakumarmeyyappan.bsky.social www.nephjc.com/news/kdigo-anemianephjc.com2026 KDIGO Anemia Management Guidelines — NephJCThis week, we will discuss 2026 KDIGO anemia management in patients with kidney disease 0159
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 11/02/2026#NephJC Jeyakumar Meyyappan from Lucknow, India . No COI Infections are a concern in kidney transplant patients. Wondering if Flozins are worth even a micro minimal risk . Good topic to be discussed 150
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 09/02/2026Here is the VA for the INFINITI study of SGLT2i in transplant patients by @glomerican.bsky.social #NephSky #Flozins #Flozination www.nephjc.com/news/2026/2/8/infiniti-the-visual-abstractnephjc.comINFINITI: The Visual Abstract — NephJCSGLT2i have reshaped cardiorenal care, but kidney transplant recipients have mostly been left out of the story. INFINITI starts to close that gap, testing the safety and physiology of dapagliflozin in... 0129
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 28/01/2026www.nephjc.com/news/... 🎨Beautiful visual abstract by Jeyakumar Meyyappan #NephJC nephjc.comPOTCAST: The Visual Abstract — NephJCCan pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? POTCAST challenges our fear of potassium. Check out the VA by Jeyakumar Meyyappan and join the #NephJC conversation 063
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 28/01/2026#nephjc Jeyakumar from Lucknow No COI 140
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 26/01/2026🍌🥑Can pushing K⁺ to the high-normal range reduce ICD shocks and hospitalizations? 🎨 #Visualabstract by @jeyakumarmeyyappan.bsky.social ⏰ #NephJC chat on Jan 27, 9 pm EST www.nephjc.com/news/2026/1/... 01310
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 14/01/2026Dr Jeyakumar from Lucknow India No COI Just curious to learn about a drug that can treat two diseases 000
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 03/12/2025#nephjc Jeyakumar from India Lurking today. Interesting study to discuss. 130
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 19/11/2025#nephjc Jeyakumar from Lucknow , India No COI 050
Reposted by Jeyakumar MeyyappanSwapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 16/02/2025Ongoing late posts from @theisn.org #ISNWCN from the high impact trial session - this was a great study design The India ALLIANCE GRACE IgAN trial Lead by Succeena Alexander from CMC Vellore #NephSky 1/ 1128
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 29/10/2025First things first — where the story starts! Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC 1145
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 29/10/2025Jeyakumar from India No COI #Nephjc 140
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 28/10/2025The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...nephjc.com2025 IgAN KDIGO guidelines: fresh out of press, already aging gracefully — NephJCThis week, we will discuss the 2025 KDIGO IgAN guidelines. which the shift from supportive care to structured, evidence-based therapy 12216
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 15/10/2025#nephjc Jeyakumar from India I believe half of my patients here don’t even take half the of prescribed protein 0.8g/kg . Interested in learning from this systematic review 050
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 13/10/2025Check at the VA for our discussion of protein diet strategies by @msocomd.bsky.social. Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? www.nephjc.com/news/2025/10...nephjc.comProtein supplementation in CKD: The Visual Abstract — NephJCWe like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do? 01313
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 16/09/2025📢 The 2025 ACC/AHA Hypertension Guideline Update is here. Join the discussion on #Bluesky tonight (9/16, 9 pm EST). We’ll unpack key changes, clinical implications, and what it means for your practice. 🫀🫘🧠 #Nephjc 0104
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 14/09/2025ISPD APCN Malaysia 2025 . Talk on fungal peritonitis in CAPD 000
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 06/09/2025🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky @brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts *the original article from @asnpublications.bsky.social www.nephjc.com/news/nephjc-...nephjc.comNephJC Shorts: MCD and FSGS Outcomes — NephJCA NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD 288
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 20/08/2025another great quote in that chapter "Stigma is a way of saying, "You deserved to have this happen," but implied within the stigma is also, "And I don't deserve it, so I don't need to worry about it happening to me." Stop blaming people for having a disease #NephJC" 3122
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 20/08/2025#nephjc Jeyakumar Meyyappan from India “Everything is tuberculosis “Read My second book on a disease. First was “emperor of all maladies “ 160
Reposted by Jeyakumar MeyyappanShellie Fravel, PharmD @shelliefravel.bsky.social · 19/08/2025“Where are the drugs? The drugs are where the disease is not. And where is the disease? The disease is where the drugs are not.” A powerful book! Looking forward to tomorrow’s book club! 052
Reposted by Jeyakumar Meyyappandanieledmonston.bsky.social @danieledmonston.bsky.social · 06/08/2025Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC 1113
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 05/08/2025😎Check out the VA for HiLO by @sejalplakhani.bsky.social 🆒 This should be quite the discussion, don't miss it! #NephJC #NephSky www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstractnephjc.comThe HiLo Trial - Visual Abstract — NephJCIs a lower versus higher phosphate target beneficial to patients undergoing hemodialysis? Check out this crisp VA by Dr Sejal Lakhani 01613
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 05/08/2025HiLo, HiLo it's off to work we go! ⛏️ Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers ⁉️ www.nephjc.com/news/hilo-tr...nephjc.comHigh or Low Phosphate? Are we Missing the (P)oint? — NephJCThis week, we will discuss the phosphate targets in dialysis. Are you aiming for HIgh or Low? 01715
Reposted by Jeyakumar MeyyappanEdgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 24/07/2025Severe AKI in the ICU: Management ca. 2025 #Nephpearls #AKIinICU #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/40578821/ 041
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 23/07/2025#nephjc Hello all , Jeyakumar from India . I stick to creatinine for most decisions. Would love to know about the gap though 140
Reposted by Jeyakumar MeyyappanChristos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/acc @christosargyrop.bsky.social · 09/07/2025My approach with the #nsmra when egfr less than 45-50 ie #flozin first. If egfr over 45 start both at the same time because #YOLO #Nephjc 052
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 09/07/2025#NephJC Hello all. This is Jeyakumar from Lucknow. No COI 140
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 08/07/2025With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' #NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social #MedSky www.nephjc.com/news/confide...nephjc.comA dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJCThis week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD. 02614
Jeyakumar Meyyappan @jeyakumarmeyyappan.bsky.social · 08/07/2025Check out the blog summary . CONFIDENCE How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ? www.nephjc.com/news/confide...nephjc.comA dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease — NephJCThis week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD. 010
Reposted by Jeyakumar MeyyappanKDIGO @kdigo.org · 16/05/2025Check out the latest KDIGO Direct: kdigo.co/KDIGO-Direct... In this issue: 📗 Nephrotic Syndrome in Children GL publishes 📢 Dr. Wanner elected KDIGO Co-Chair 💔 KDIGO mourns Dr. Rinaldo Bellomo 🌍 KDIGO convenes Green Dialysis Conference 🏛️ KDIGO at #ERA25 🎥 New resources on #ADPKD, #C3G, #CKM & #IgAN 011
Reposted by Jeyakumar MeyyappanNephrology Journal Club @nephjc.bsky.social · 13/05/2025👋Want to get my attention...start bleeding 🩸 Hey #NephSky #NephJC fans! Check out the VA on ddAVP and kidney biopsy bleeding for tonite's discussion on #bluesky at 9pm by Dr. Divya Bajpai www.nephjc.com/news/2025/5/13/desmopressin-for-kidney-biopsy-the-visual-abstractnephjc.comDesmopressin for kidney biopsy - The Visual abstract — NephJCDoes desmopressin reduce the risjk of post kidney biopsy bleeding? Checkout the beautiful VA answering this practical question by NSMC faculty Dr Divya Bajpai 0105
